Bajaj Finserv Mutual FundEquity Scheme - Flexi Cap Fund3.2 years
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related instruments across market capitalisation.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 100% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Buy checklist
History depth
Watch
3.2 years - usable, still building a track record.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
1.00% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -17.5%. Ask whether you can hold through a similar fall.
Vs category
Pass
100% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Pass
Nimesh Chandan · 3.3 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 35.9% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 18%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
27 Sept 2024 – 30 Jun 2025
Trough 3 Mar 2025 · recovered in 119 days
-17.5%
17 Nov 2025 – 17 Jun 2026
Trough 23 Mar 2026 · recovered in 86 days
-13.8%
31 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-9.0%
3 Jun 2024 – 7 Jun 2024
Trough 4 Jun 2024 · recovered in 3 days
-5.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
87
Vs category
79
Consistency
100
Risk-adjusted
60
Drawdown
56
Mean
76
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
Supporting reads
30 Sept 2026 · 71 holdings · top 10 are 35.9%.
HDFC Bank Ltd
Financial
5.9%
ICICI Bank Ltd
Financial
5.5%
Others CBLO
Unspecified
4.1%
Reliance Industries Ltd
Energy & Utilities
3.9%
Divi's Laboratories Ltd
Healthcare
3.6%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
19 Oct 2026
DECISION
Status moved from HEALTHY to MONITOR.
19 Oct 2026
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Sundaram Mutual Fund
Caveat: Lower trailing returns
Capitalmind Mutual Fund
Caveat: Higher TER · Lower trailing returns
Unifi Mutual Fund
Caveat: Higher TER · Lower trailing returns
Bank of India Mutual Fund
Caveat: Higher volatility · Deeper drawdown
ITI Mutual Fund
Caveat: Higher volatility · Deeper drawdown
Bajaj Finserv Mutual FundEquity Scheme - Flexi Cap Fund3.2 years
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related instruments across market capitalisation.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 100% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Buy checklist
History depth
Watch
3.2 years - usable, still building a track record.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
1.00% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -17.5%. Ask whether you can hold through a similar fall.
Vs category
Pass
100% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Pass
Nimesh Chandan · 3.3 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 35.9% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 18%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
30 Oct 2026 · -0.1% over 1Y
15.617
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
30 Oct 2026
-6.1%
27 Sept 2024 – 30 Jun 2025
Trough 3 Mar 2025 · recovered in 119 days
-17.5%
17 Nov 2025 – 17 Jun 2026
Trough 23 Mar 2026 · recovered in 86 days
-13.8%
31 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-9.0%
3 Jun 2024 – 7 Jun 2024
Trough 4 Jun 2024 · recovered in 3 days
-5.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
87
Vs category
79
Consistency
100
Risk-adjusted
60
Drawdown
56
Mean
76
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
Supporting reads
30 Sept 2026 · 71 holdings · top 10 are 35.9%.
HDFC Bank Ltd
Financial
5.9%
ICICI Bank Ltd
Financial
5.5%
Others CBLO
Unspecified
4.1%
Reliance Industries Ltd
Energy & Utilities
3.9%
Divi's Laboratories Ltd
Healthcare
3.6%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
19 Oct 2026
DECISION
Status moved from HEALTHY to MONITOR.
19 Oct 2026